Related Experiment Video
Updated: May 23, 2026
10:41
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
Waldenström macroglobulinemia
1Division of Hematology, Mayo Clinic, 200 First Street, SW, Siebens 667, Rochester, MN 55905, USA. gertz.morie@mayo.edu
Hematology (Amsterdam, Netherlands)
|April 18, 2012
Summary
Waldenström macroglobulinemia is a rare lymphoma characterized by IgM monoclonal protein. Current treatments, including rituximab, cyclophosphamide, and dexamethasone, have improved median survival to over 10 years.
Area of Science:
- Hematology
- Oncology
- Clinical Medicine
Background:
- Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma defined by a serum monoclonal IgM protein.
- Clinical manifestations include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and hyperviscosity syndrome.
- Prognostic stratification utilizes the International Staging System based on age, hemoglobin, platelets, IgM, and beta2 microglobulin levels.
Purpose of the Study:
- To provide a comprehensive overview of Waldenström macroglobulinemia.
- To discuss diagnostic criteria, clinical features, and prognostic factors.
- To review current and emerging therapeutic agents and treatment strategies.
Main Methods:
- Literature review of Waldenström macroglobulinemia diagnosis, staging, and treatment.
- Analysis of clinical features and prognostic indicators.
- Summary of active treatment agents and preferred therapeutic regimens.
Main Results:
- Diagnosis requires a serum monoclonal IgM protein.
- The International Staging System aids in prognostic assessment.
- Median survival for WM now exceeds 10 years with modern therapies.
Conclusions:
- Waldenström macroglobulinemia is a distinct lymphoma entity with characteristic clinical and laboratory findings.
- Effective treatment strategies have significantly improved patient outcomes.
- Ongoing research continues to refine therapeutic approaches for WM.